Table 1.
Participant Characteristicsa
| Characteristics | Group A Undifferentiated SoloSTARb | Group B Differentiated SoloSTARc | Group C FlexPen |
|---|---|---|---|
| N | 100 | 100 | 200 |
| Males/females (%) | 44/56 | 51/49 | 50/50 |
| Age (average) | 50.3 | 49.0 | 48.8 |
| Age (%) | |||
| 18–49 years | 45 | 52 | 50 |
| 50 years or older | 55 | 48 | 50 |
| Diabetes (%) | |||
| Type 1 | 20 C | 16 | 12 |
| Type 2 | 80 | 84 | 88 A |
| Treatment type (%) | |||
| Insulin (± OADsd) | 34 | 37 | 36 |
| OADs (no insulin) | 66 | 63 | 64 |
a
Statistical testing: Upper case letter indicates a statistic is significantly higher at the 90% confidence level between groups.
b
Two participant(s) were color blind.
c
One participant was color blind.
d
(OAD) oral antidiabetic drug